Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades

Published:2021-09 Issue:9 Volume:21 Page:580-597
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kantarjian Hagop M.,Short Nicholas J.,Fathi Amir T.,Marcucci Guido,Ravandi Farhad,Tallman Martin,Wang Eunice S.,Wei Andrew H.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference203 articles.

1. Acute myeloid leukaemia;Short;Lancet,2018

2. Toward individualized therapy in acute myeloid leukemia: a contemporary review;Kadia;JAMA Oncol,2015

3. Acute myeloid leukemia—current progress and future directions;Kantarjian;Blood Cancer J,2021

4. Intensive postremission chemotherapy in adults with acute myeloid leukemia: Cancer and Leukemia Group B;Mayer;N Engl J Med,1994

5. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N Engl J Med,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice;Molecular Therapy - Nucleic Acids;2024-09

2. Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia;Journal of Cancer Research and Clinical Oncology;2024-03-20

3. Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell lines;2024-02-27

4. Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda;Cancers;2024-01-16

5. Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions;Experimental Hematology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3